Table 3.

Sequential Models for the Odds of Poor Low-Density Lipoprotein Cholesterol Control (>70 mg/dL)

Variable	Level	Outcome: LDL >70
		Base model	With race*location	Full model
Year	(Per year)	0.92 (0.92–0.92)	0.92 (0.92–0.92)	0.92 (0.92–0.92)
Location of residence	Urban	Ref
	Rural	1.13 (1.12–1.14)
Race–ethnicity	Non-Hispanic white	Ref
	Non-Hispanic black	1.41 (1.39–1.43)
	Hispanic	1.14 (1.12–1.16)
	Other race	1.04 (1.01–1.07)
Race*location	Non-Hispanic white*urban		Ref	Ref
	Non-Hispanic white*rural		1.14 (1.13–1.15)	1.15 (1.14–1.16)
	Non-Hispanic black*urban		1.41 (1.39–1.43)	1.36 (1.34–1.38)
	Non-Hispanic black*rural		1.59 (1.53–1.64)	1.55 (1.5–1.6)
	Hispanic*urban		1.15 (1.13–1.17)	1.06 (1.04–1.08)
	Hispanic*rural		1.17 (1.11–1.23)	1.11 (1.05–1.16)
	Other race*urban		1.06 (1.02–1.09)	1.02 (0.98–1.05)
	Other race*rural		1.14 (1.08–1.2)	1.13 (1.07–1.19)
Sex	Male			Ref
	Female			1.58 (1.52–1.65)
Age	(Per year)			1 (1–1)
Marital status	Married			Ref
	Unmarried			1.05 (1.04–1.06)
Disability	>50% service-related			0.99 (0.98–1.01)
Smoking status	Nonsmoker			Ref
	Smoker			1 (0.98–1.01)
A1C	≤8%			Ref
	>8%			1.13 (1.12–1.14)
Number primary care visits	Per year			1 (1–1)
Major adverse cardiac events	Acute coronary syndrome			1.02 (1.01–1.03)
	Atherosclerotic cerebrovascular disease			1.04 (1.03–1.05)
	Coronary heart disease			0.75 (0.74–0.76)
	Peripheral artery disease			0.99 (0.98–0.99)
Statins prescribed	No statins			Ref
	Statins at regular dose			0.55 (0.55–0.56)
	Intense statin dose			0.57 (0.56–0.58)
Dual VA-CMS status	>80% VA utilization			Ref
	50–80% VA utilization			1.03 (1.02–1.04)
	<50% VA utilization			0.97 (0.96–0.98)

The gray shading is to indicate that the terms corresponding to these rows are omitted.

ORs (95% CIs) for GEE models.